ClinicalTrials.Veeva

Menu

Bispectral Index Guiding Etomidate Used in Children Aged 3 to 10 for Clinical Anesthesia Induction

Z

Zhengzhou University

Status and phase

Unknown
Phase 4

Conditions

Induction
Etomidate
Pediatric
Bispectral Index

Treatments

Drug: sevoflurane
Drug: propofol
Drug: etomidate

Study type

Interventional

Funder types

Other

Identifiers

NCT02182648
etomidate children 20140625

Details and patient eligibility

About

This research through using bispectral index to guide the induced dose and speed of etomidate lipid emulsion for pediatric total venous anesthesia,and to provide a reference for clinical anesthesia physician.

Enrollment

120 estimated patients

Sex

All

Ages

3 to 10 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. obtain informed consent;
  2. undergoing elective hypospadias repair surgery under general anesthesia;
  3. American society of anesthesiologists (ASA) class I-II;
  4. aged between 3-10 years old;
  5. BMI is 18.5-30 kg/m2;

Exclusion criteria

  1. systolic blood pressure≥180 mmHg or<90 mmHg, diastolic blood pressure≥110 mmHg or<60 mmHg;
  2. serious heart, brain, liver, kidney, lung, endocrine diseases or serious infections;
  3. long-term use of hormone or a history of adrenal cortex inhibition;
  4. suspected or confirmed difficult airway;
  5. suspected or confirmed abuse of narcotic analgesic drugs, psychotropic drugs;
  6. neuromuscular disease;
  7. mental instability, or have a mental illness;
  8. allergic to investigational products or with other contraindication
  9. participated in other study within 30 days

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

120 participants in 3 patient groups

etomidate group
Experimental group
Description:
infusion of etomidate at 2 minutes before anesthesia induction
Treatment:
Drug: etomidate
propofol group
Active Comparator group
Description:
infusion of propofol at 2 minutes before anesthesia induction
Treatment:
Drug: propofol
sevoflurane group
Active Comparator group
Description:
inhale sevoflurane for anesthesia induction and maintenance
Treatment:
Drug: sevoflurane

Trial contacts and locations

0

Loading...

Central trial contact

Enqiang Chang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems